Cytek Biosciences (NASDAQ:CTKB) specializes in the development and manufacturing of advanced flow cytometry products. Its cutting-edge solutions are designed to support researchers and clinicians in various fields such as immunology, cell biology, and cancer research by providing detailed cell analysis. Cytek's product portfolio includes innovative flow cytometers that offer high-dimensional data while maintaining ease of use and cost-effectiveness. At the heart of Cytek's objectives is the commitment to enhancing precision medicine and improving patient outcomes through more accessible and advanced cellular analysis technologies. Through continuous innovation and strategic partnerships, Cytek aims to expand its global footprint and drive advancements in life science research and clinical diagnostics.